Infectious disease response
3 European H2020 organizations list this as part of their work.
Most active in this area
- UNIVERSITE CHEIKH ANTA DIOP
Senegal's leading university contributing West African field expertise in climate-migration, marine governance, and social sciences to international research consortia.
“REACTION evaluated the antiviral drug favipiravir (T-705) during the Ebola outbreak, contributing clinical field capacity in West Africa.”
SN7 projects - FINOVATIS
French SME providing health economics, pharmacoeconomic modeling, and market access analysis for advanced therapy and drug repurposing research consortia.
“MANCO (2020) on monoclonal antibodies against COVID-19 shows capacity to pivot rapidly to emerging public health needs.”
SMEFR4 projects - JANSSEN-CILAG
French J&J pharmaceutical subsidiary contributing industry drug-development expertise to EU computational biomedicine and infectious disease consortia.
“ZIKAlliance (2016-2021) was a global alliance for Zika virus control and prevention, where Janssen-Cilag participated as a third party, likely contributing vaccine or antiviral development expertise.”
FR2 projects